Engaging patients, advocates, and researchers to improve the lives of young people with rare cancers
The MyPART (My Pediatric and Adult Rare Tumor) Network
The MyPART Network
Learn more about the MyPART group of scientists, patients, family members, advocates, and health care providers working on rare tumors.
Participate in Our Trial
Help speed up the development of new treatments by giving researchers the tools they need.
Why We Study Rare Cancers
Rare cancers make up about a quarter of all cancer cases. Learn why we are committed to studying these cancers.
Research on Rare Tumors
Study Confirms Atezolizumab’s Effectiveness Against a Rare Sarcoma
For people with alveolar soft part sarcoma, immunotherapy drug offers new option.
A Potentially Major Advance for Treating Desmoid Tumors
Nirogacestat treatment shrinks tumors, improves progression-free survival, and reduces pain.
Selumetinib Approved by FDA to Treat Children with NF1
NCI-led trial showed drug shrank tumors, improved quality of life.